Other
CYCLOPROPYLBIMATOPROST
Safety score · 0–100
Avoid
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
A close cousin of the prescription glaucoma drug bimatoprost. Used illegally in some lash serums; can darken iris, sink eyelids, and cause periorbital fat loss.
Function
Skin benefits
- No legitimate cosmetic benefit
Known concerns
- Prostaglandin analog drug, not a cosmetic
- Same class as bimatoprost (Latisse) prescription only
- Eye risks: iris pigmentation change, periorbital fat loss, eyelid darkening
- Not approved for OTC cosmetic use in EU
- Adulteration concern in lash serums
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related others
Check your shelf
Find CYCLOPROPYLBIMATOPROST in your products.
Scan any cosmetic product with LuxSense to see if it contains CYCLOPROPYLBIMATOPROST and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.